The Agency for Healthcare Research and Quality (AHRQ) has named Gil Alterovitz its inaugural Chief Super Intelligence Officer, a role he holds alongside his position as Chief Data Officer (CDO). Alterovitz shared the news in a LinkedIn post, noting his plans to continue assembling a team for the agency’s mission. His work focuses on developing super intelligence for evidence, data, and implementations aimed at improving health outcomes for the American people.

Alterovitz’s work at the U.S. Department of Veterans Affairs (VA) and the Veterans Health Administration (VHA) has included founding the National Artificial Intelligence Institute, serving as its inaugural director and as Chief AI Officer for VA/VHA, and helping develop the VA’s first AI strategy and department-wide Trustworthy AI Framework.

At Harvard Medical School, Alterovitz serves as an Associate Professor and Director of the Biomedical Cybernetics Laboratory, where he has led international efforts focused on drug-resistant diseases. His work also includes clinical genomics and health data standards, including leading the design of SMART-on-FHIR Genomics and HL7 FHIR Genomics.

Alterovitz also serves as President of the Presidential Innovation Fellows Foundation, a nonprofit organization. In 2025, he served as Senior Advisor to the Director and inaugural Chief AI Officer at the National Institutes of Health.